496 related articles for article (PubMed ID: 27701752)
1. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2012 May; (5):CD002827. PubMed ID: 22592686
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2006 Apr; (2):CD002827. PubMed ID: 16625561
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2003; (1):CD002827. PubMed ID: 12535440
[TBL] [Abstract][Full Text] [Related]
5. Treatment for IgG and IgA paraproteinaemic neuropathy.
Stork AC; Lunn MP; Nobile-Orazio E; Notermans NC
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD005376. PubMed ID: 25803231
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Bus SR; de Haan RJ; Vermeulen M; van Schaik IN; Eftimov F
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD001797. PubMed ID: 38353301
[TBL] [Abstract][Full Text] [Related]
8. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
9. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead TJ; Chalk CH; Parks NE
Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
Cochrane Database Syst Rev; 2013 Dec; (12):CD001797. PubMed ID: 24379104
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin for multifocal motor neuropathy.
Keddie S; Eftimov F; van den Berg LH; Brassington R; de Haan RJ; van Schaik IN
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD004429. PubMed ID: 35015296
[TBL] [Abstract][Full Text] [Related]
12. Treatment for IgG and IgA paraproteinaemic neuropathy.
Allen D; Lunn MP; Niermeijer J; Nobile-Orazio E
Cochrane Database Syst Rev; 2007 Jan; (1):CD005376. PubMed ID: 17253554
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Doets AY; Hughes RA; Brassington R; Hadden RD; Pritchard J
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD008630. PubMed ID: 31981368
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy.
Léger JM; Viala K; Nicolas G; Créange A; Vallat JM; Pouget J; Clavelou P; Vial C; Steck A; Musset L; Marin B;
Neurology; 2013 Jun; 80(24):2217-25. PubMed ID: 23667063
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2013 Jun; (6):CD003280. PubMed ID: 23771584
[TBL] [Abstract][Full Text] [Related]
17. A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.
Mariette X; Chastang C; Clavelou P; Louboutin JP; Leger JM; Brouet JC
J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):28-34. PubMed ID: 9221964
[TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.
Dalakas MC; Rakocevic G; Salajegheh M; Dambrosia JM; Hahn AF; Raju R; McElroy B
Ann Neurol; 2009 Mar; 65(3):286-93. PubMed ID: 19334068
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2012 Jul; (7):CD002063. PubMed ID: 22786476
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; Swan AV; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2010 Nov; (11):CD003280. PubMed ID: 21069674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
